Ownership research and analyst forecasts provide insights into stock opportunities. Pyxis Oncology, Inc. (NASDAQ: PYXS) is primarily owned by institutions, with key shareholders like Pfizer Inc. and hedge funds. Insights from shareholder types and analyst forecasts can help in understanding a stock's potential.